DIERKS CHRISTINE,WARMUTH MARKUS,DIERKS Christine,WARMUTH Markus
申请号：
SI200830983
公开号：
SI2187967T1
申请日:
2008.08.13
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
This invention provides a combination of antagonists of the hedgehog signaling pathway with a BCR-ABL inhibitor. The combination of the present invention may be used for treating cancers known to be associated with protein tyrosine kinases such as, for example, Src, BCR-ABL and c-kit.
